Bicillin L-a Injection, Suspension
NDC Package 60793-702-10
Package Information
Bicillin L-a (penicillin g benzathine) injection is penicillin G benzathine is used to treat a wide variety of bacterial infections. This formulation utilizes a injection, suspension delivery system. Marketed by Pfizer Laboratories Div Pfizer Inc, this product is identified by NDC 60793-702 and is authorized under FDA application NDA050141.
Identification & Billing
- RxCUI: 731564 - penicillin G benzathine 600,000 UNT in 1 ML Prefilled Syringe
- RxCUI: 731564 - 1 ML penicillin G benzathine 600000 UNT/ML Prefilled Syringe
- RxCUI: 731564 - penicillin G benzathine 600,000 UNT per 1 ML Prefilled Syringe
- RxCUI: 731566 - BICILLIN L-A 600,000 UNT in 1 ML Prefilled Syringe
- RxCUI: 731566 - 1 ML penicillin G benzathine 600000 UNT/ML Prefilled Syringe [Bicillin L-A]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 60793 - Pfizer Laboratories Div Pfizer Inc
- 60793-702 - Bicillin L-a
- 60793-702-10 - 10 SYRINGE in 1 PACKAGE / 4 mL in 1 SYRINGE (60793-702-04)
- 60793-702 - Bicillin L-a
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 60793-702-10 identifies a specific commercial package of 10 syringe in 1 package / 4 ml in 1 syringe (60793-702-04) of Bicillin L-a, a human prescription drug labeled by Pfizer Laboratories Div Pfizer Inc. This injection, suspension is formulated for intramuscular use and contains penicillin g benzathine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pfizer Laboratories Div Pfizer Inc on June 27, 1952. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Penicillin G benzathine is used to treat a wide variety of bacterial infections. It may also be used to prevent certain bacterial infections (such as rheumatic fever). This medication is a long-acting penicillin antibiotic. It works by stopping the growth of bacteria.
How is this Pfizer Laboratories Div Pfizer Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 60793070210. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.